NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
Position in MYGN — Myriad Genetics Inc
CIK 921739
PHILADELPHIA, PA
Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$285,500
+$60,500 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 196 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT INTERNATIONAL INC. holds $969,998,094 across 16 Diagnostics & Research names. MYGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,295,020 | $246,675,409 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
421,519 | $221,904,462 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
360,056 | $180,517,676 | |
| 4 | NEO |
Neogenomics Inc
|
5,037,787 | $73,501,312 | |
| 5 | ILMN |
Illumina, Inc.
|
282,402 | $49,654,743 | |
| 6 | GH |
Guardant Health, Inc.
|
330,145 | $49,531,654 | |
| 7 | DGX |
Quest Diagnostics Inc
|
232,797 | $49,341,324 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
204,232 | $39,461,707 |
All Filings in MYGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,500 | 50,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $225,000 | 50,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $307,500 | 50,000 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||